Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125304
Filing Date
2024-11-12
Accepted
2024-11-12 16:01:22
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tecx-20240930.htm   iXBRL 10-Q 2429846
2 EX-10.1 tecx-ex10_1.htm EX-10.1 29079
3 EX-31.1 tecx-ex31_1.htm EX-31.1 13844
4 EX-31.2 tecx-ex31_2.htm EX-31.2 13947
5 EX-32.1 tecx-ex32_1.htm EX-32.1 9162
  Complete submission text file 0000950170-24-125304.txt   7922101

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tecx-20240930.xsd EX-101.SCH 1171695
67 EXTRACTED XBRL INSTANCE DOCUMENT tecx-20240930_htm.xml XML 1033727
Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Filer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 241447756
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)